RA Capital Management's Medical Device Portfolio

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

Ceribell focuses on making electroencephalography accessible, efficient, and cost-effective.

Empatica is an affective computing company focused on human data analytics.

Exo is a medical device startup which develops handheld ultrasound devices and AI for imaging and therapeutic applications.

MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.

VitriVax is a formulation technology company that engineers solutions to maximize the accessibility and utility of human vaccines.

Innoventric, a start-up company from Ness-Ziona, Israel, develops the unique Trillium technology

Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.

Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.

Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.

Magenta Medical is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.

PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

We transform the management of OUD to help people begin and sustain recovery.